Decreasing childhood pertussis infection through vaccination of the elderly

Consultant Pharmacist

Volumn 23, Issue 12, 2008, Pages 976-981

  Higginbotham, Tanner W ^a   Cleveland, Kevin W ^a  

^a IDAHO STATE UNIVERSITY   (United States)

Author keywords

Diphtheria; Geriatrics; Pertussis; Pertussis transmission; Source of transmission; Tetanus; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS VACCINE;

BORDETELLA PERTUSSIS; CHILDHOOD DISEASE; DISEASE TRANSMISSION; DRUG SAFETY; ELDERLY CARE; ERYTHEMA; FEVER; HUMAN; IMMUNOGENICITY; OFF LABEL DRUG USE; PAIN; PERTUSSIS; REVIEW; SWELLING; VACCINATION;

EID: 57749188875     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2008.976     Document Type: Review

References (22)

1. Broder KR, Cortese MM, Iskander JK et al; Advisory Committee on Immunization Practices (ACIP). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006;55:1-34.
2. Kretsinger K, Broder KR, Cortese MM et al; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. MMWR Recomm Rep 2006;55:1-37.
3. CDC. Summary of notifiable diseases, United States, 2006. MMWR 2008;55.
4. CDC. Summary of notifiable diseases, United States, 1996. MMWR 1997;45.
5. Wirsing van König CH, Postels-Multani S, Bock HL et al. Pertussis in adults: frequency of transmission after household exposure. Lancet 1995;346:1326-9.
6. Lambert HJ. Epidemiology of a small pertussis outbreak in Kent County, Michigan. Public Health Rep 1965;80:365-9.
7. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed) 1988;296:612-4.
8. Simondon F, Preziosi MP, Yam A et al. Randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine 1997;15:1606-12.
9. Salmaso S, Mastrantonio P, Tozzi AE et al. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Pediatrics 2001;108:E81.
10. Tan T, Trindade E, Skowronski D et al. Epidemiology of pertussis. Pediatr Infect Dis J 2005;24: Suppl:10-18
11. Wendelboe AM, Van Rie A, Salmaso S et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005;24:Suppl:58-61.
12. Cortese MM, Baughman AL, Brown K et al. A "new age" in pertussis prevention: new opportunities through adult vaccination. Am J Prev Med 2007;32:177-85.
13. Strebel P, Nordin J, Edwards K et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 2001;183:1353-9.
14. Ward JI, Cherry JD, Chang SJ et al. Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med 2005;353:1555-63.
15. Nennig ME, Shinefield HR, Edwards KM et al. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996;275:1672-4.
16. Wendelboe AM, Njamkepo E, Bourillon A et al; Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J 2007;26:293-9.
17. Bisgard KM, Pascual FB, Ehresmann KR et al. Infant pertussis: who was the source? Pediatr Infect Dis J 2004;23:985-9.
18. US Census Bureau. Population 65 years and over in the United States: table s0103. 2006 American Community Survey; 2006 Summary Tables. Available at http://factfinder.census.gov. Accessed June 3, 2008.
19. US Census Bureau. Grandchildren characteristics: table s1001. 2006 American Community Survey; 2006 Summary Tables. Available at http://factfinder.census.gov. Accessed June 3, 2008.
20. Sanofi Pasteur Limited. Adacel. Tdap vaccine: tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed. VRBPAC briefing document 2005 Feb.
21. Galazka AM. Tetanus: the immunological basis for immunization. World Health Organization; 1993. The Immunological Basis for Immunization Series, Module 3, No. WHO/EPI/GEN/93.12.
22. Galazka AM. Diphtheria: the immunological basis for immunization. World Health Organization; 1993. The Immunological Basis for Immunization Series, Module 2, No.WHO/EPI/GEN/93.12.